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Predicting and Detecting Arm Motor Gains in a Trial of Robotic Therapy 
Alison L McKenzie, Chapman Univ, Orange, CA; Lucy Der Yeghiaian, Jill See, Dennis 
Nguyen, Vu Le, Steven C Cramer; Univ of California, Irvine, Irvine, CA 
Introduction: Optimal patient selection and patient assessment can maximize the likelihood 
that a clinical trial of a restorative therapy will detect treatment-induced behavioral gains when 
present. The current analysis compared multiple arm motor assessments for ability to predict, 
and to detect, clinically meaningful behavioral gains from robotic therapy. Methods: Enrollees 
were combined across 3 studies that provided 23-24 hours of standardized arm motor robotic 
therapy, which consisted of repeated grasp-release affected hand movements. Entry criteria 
included age >18 yr, stroke >3 mo prior, >5 deg range of motion in affected index finger 
MCP, >25% prolongation to complete 9-hole pegboard (9HP), and no severe apraxia/sensory 
loss/aphasia/depression. Prior to and at end of therapy, patients were assessed on 8 different 
measures of arm motor status: Fugl-Meyer Arm Motor Scale (FM-total), Fugl-Meyer Arm Motor 
Scale-Hand Subsection (FM-Hand), Action Research Arm Test, Box/Blocks Test, time to 
complete 9HP, hand motor subscale of SIS-2, force of grasping, and force of pinching. Analyses 
used non-parametric statistics to (1) examine prediction of treatment gains; for each measure, 
baseline score was correlated with change in that score. (2) examine responsiveness of each 
scale, defined as percentage of subjects in whom the change in score exceeded 10% of that 
score's maximum value. Results: The 37 patients had a wide range of arm motor deficits at 
baseline, e.g., baseline FM scores ranged from 14-60 (38 +/- 15, mean +/- SD), with 38% 
having some aphasia and a wide range of generally moderate sensory deficits. Baseline scores 
were normally distributed for none of the 8 measures, instead showing tails at one or both 
ends. In terms of predictors, no single scale showed a signtticant and meaningful prediction 
across all subjects. However, among weaker patients (i.e., excluding patients in top quartile, 
as defined for each scale), FM-hand and FM-total (r=0.5, P<0.02 for both) were each 
signtticant predictors; among stronger patients (remove bottom quartile), Box/Blocks emerged 
as a significant predictor (r=0.57, P<0.04). In terms of responsiveness, SIS performed best 
(49% of subjects improved by 10% maximum score), followed by pinch and FM-hand. When 
analyzing only the 19 strongest or the 18 weakest patients, SIS remained the best performer. 
Conclusions: In a clinical trial setting, choice of test instrument is important for optimizing 
patient selection and for detecting treatment-induced gains when present. In the setting of arm 
motor therapy for chronic stroke, best prediction of treatment gains was achieved by using one 
test for weaker patients and a different test for stronger patients-no one test covered all. In 
terms of responsiveness, the self-rated SIS performed best. These results may be useful for 
guiding entry crtteria and outcome measures in clinical trials of restorative agents. 
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